SANT 2
SANT 2 is a potent Hh-signaling pathway antagonist. SANT 2 interferes with the expression of Gli1. SANT 2 causes developmental delay in medaka embryos. SANT 2 has the potential for the research of several malignancies including Gorlin syndrome (a disorder predisposing to basal cell carcinoma, medulloblastoma and rhabdomyosarcoma), prostate, pancreatic and breast cancers[1][2].
Product Specifications
CAS Number
329196-48-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Gli; Hedgehog
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Cancer-programmed cell death
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/sant-2.html
Purity
99.41
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
ClC1=CC=C(NC(C2=CC(OCC)=C(OCC)C(OCC)=C2)=O)C=C1C3=NC4=CC=CC=C4N3
Molecular Formula
C26H26ClN3O4
Molecular Weight
479.96
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD20 / MS4A1 (B-Cell Marker) (IGEL/1497R), CF640R conjugate, 0.1mg/mL
Angiotensin I Converting Enzyme (ACE) / CD143 (9B9), CF405S conjugate, 0.1mg/mL
![ATP5F1B Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI6C4]](https://cdn.genprice.uk/products/937/6868c319994c49e6dc3eef6b/imageurl/ta500834bm.webp)